Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06174493 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 12, 2024 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jan 2025 to Jan 2026 Start date: Jan 2024 to Jan 2025 · Completion date: Jan 2026 to Jan 2027v2 Show 2 more changesShow less
    • Start date: Jan 2024 to Jan 2025
    • Completion date: Jan 2026 to Jan 2027
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Clinical trials, specifically focused on atopic dermatitis, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation. The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
Trial Details
NCT Number NCT06174493
Lead Sponsor Power Life Sciences Inc.
Conditions Atopic Dermatitis
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov